{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:31:01Z","timestamp":1791390661110,"version":"4.3.3"},"reference-count":124,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2014,10,17]],"date-time":"2014-10-17T00:00:00Z","timestamp":1413504000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0110469","type":"journal-article","created":{"date-parts":[[2014,10,20]],"date-time":"2014-10-20T17:51:02Z","timestamp":1413827462000},"page":"e110469","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":39,"title":["Clinical Practice Guidelines and Consensus Statements in Oncology \u2013 An Assessment of Their Methodological Quality"],"prefix":"10.1371","volume":"9","author":[{"given":"Carmel","family":"Jacobs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian D.","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Makarski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha\u00ebl","family":"Chass\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean","family":"Fergusson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Hutton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Clemons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,10,17]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1136\/bmj.318.7182.527","article-title":"Potential benefits, limitations, and harms of clinical guidelines","volume":"318","author":"SH Woolf","year":"1999","journal-title":"BMJ"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/0140-6736(93)92244-N","article-title":"Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations","volume":"342","author":"JM Grimshaw","year":"1993","journal-title":"Lancet"},{"key":"ref3","unstructured":"Graham RMM, Miller Wolman D, Greenfield S, Steinberg E, Editors, Committee on Standards for Developing Trustworthy Clinical Practice Guidelines Clinical Practice Guidelines We Can Trust.: Institute of Medicine."},{"key":"ref4","unstructured":"(2009) Mosby&apos;s Medical Dictionary. 8th Edition ed: Elsevier."},{"key":"ref5","doi-asserted-by":"crossref","first-page":"E839","DOI":"10.1503\/cmaj.090449","article-title":"AGREE II: advancing guideline development, reporting and evaluation in health care","volume":"182","author":"MC Brouwers","year":"2010","journal-title":"Cmaj"},{"key":"ref6","unstructured":"Guidelines International Network. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.g-i-n.net\/\" xlink:type=\"simple\">http:\/\/www.g-i-n.net\/<\/ext-link>. Accessed 26 May 2014."},{"key":"ref7","unstructured":"Canadian partnership against cancer and pCODR. (2013) How cancer drug funding decisions are made Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.pcodr.ca\/idc\/groups\/pcodr\/documents\/pcodrdocument\/pcodr-funding-tutorial.pdf\" xlink:type=\"simple\">http:\/\/www.pcodr.ca\/idc\/groups\/pcodr\/documents\/pcodrdocument\/pcodr-funding-tutorial.pdf<\/ext-link>. Accessed 28 April 2014."},{"key":"ref8","unstructured":"Brouwers (2010) Standards and Guidelines Evidence (SAGE) Directory of Cancer Guidelines. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.cancerview.ca\/cv\/portal\/Home\/TreatmentAndSupport\/TSProfessionals\/ClinicalGuidelines\/GRCMain\/GRCSAGE?_afrLoop=176960541903000&lang=en&_afrWindowMode=0&_adf.ctrl-state=n8sm6f4dx_85\" xlink:type=\"simple\">http:\/\/www.cancerview.ca\/cv\/portal\/Home\/TreatmentAndSupport\/TSProfessionals\/ClinicalGuidelines\/GRCMain\/GRCSAGE?_afrLoop=176960541903000&amp;lang=en&amp;_afrWindowMode=0&amp;_adf.ctrl-state=n8sm6f4dx_85<\/ext-link>. Accessed 28 September 2013."},{"key":"ref9","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1586\/erp.11.11","article-title":"Inventory of Cancer Guidelines: a tool to advance the guideline enterprise and improve the uptake of evidence","volume":"11","author":"MC Brouwers","year":"2011","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"ref10","unstructured":"Oncology JoC Information for Contributors."},{"key":"ref11","doi-asserted-by":"crossref","first-page":"4919","DOI":"10.1200\/JCO.2009.22.3214","article-title":"Venous Thromboembolism Prophylaxis and Treatment in Cancer: A Consensus Statement of Major Guidelines Panels and Call to Action","volume":"27","author":"AA Khorana","year":"2009","journal-title":"Journal of Clinical Oncology"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3747\/co.v13i6.124","article-title":"Recommendations of the canadian consensus group on the management of chronic myeloid leukemia","volume":"13","author":"P Laneuville","year":"2006","journal-title":"Curr Oncol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3747\/co.2007.131","article-title":"Updated recommendations from the Canadian National Consensus Meeting on HER2\/neu testing in breast cancer","volume":"14","author":"W Hanna","year":"2007","journal-title":"Curr Oncol"},{"key":"ref14","first-page":"50","article-title":"Curr Oncol","volume":"16","year":"2009"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3747\/co.v16i1.393","article-title":"The role of the epidermal growth factor receptor tyrosine kinase inhibitors as therapy for advanced, metastatic, and recurrent non-small-cell lung cancer: a Canadian national consensus statement","volume":"16","author":"PM Ellis","year":"2009","journal-title":"Curr Oncol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3747\/co.v17i6.670","article-title":"Consensus recommendations for the use of anti-egfr therapies in metastatic colorectal cancer","volume":"17","author":"C Cripps","year":"2010","journal-title":"Curr Oncol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3747\/co.v17i3.610","article-title":"Eastern Canadian Colorectal Cancer Consensus Conference: setting the limits of resectable disease","volume":"17","author":"M Vickers","year":"2010","journal-title":"Curr Oncol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3747\/co.v17i3.484","article-title":"Consensus recommendations for the diagnosis and management of well-differentiated gastroenterohepatic neuroendocrine tumours: a revised statement from a Canadian National Expert Group","volume":"17","author":"W Kocha","year":"2010","journal-title":"Curr Oncol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3747\/co.v17i2.555","article-title":"Diagnosis and management of hepatocellular carcinoma: results of a consensus meeting of The Ottawa Hospital Cancer Centre","volume":"17","author":"T Asmis","year":"2010","journal-title":"Curr Oncol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"228","DOI":"10.3747\/co.v18i5.952","article-title":"Multidisciplinary Canadian consensus recommendations for the management and treatment of hepatocellular carcinoma","volume":"18","author":"M Sherman","year":"2011","journal-title":"Curr Oncol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"e180","DOI":"10.3747\/co.v18i4.779","article-title":"Canadian Expert Group consensus recommendations: KRAS testing in colorectal cancer","volume":"18","author":"F Aubin","year":"2011","journal-title":"Curr Oncol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"e468","DOI":"10.3747\/co.19.1167","article-title":"Report from the 13th annual Western canadian gastrointestinal cancer consensus conference; calgary, alberta; september 8\u201310, 2011","volume":"19","author":"MM Vickers","year":"2012","journal-title":"Curr Oncol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3747\/co.20.1277","article-title":"Consensus recommendations for cancer rehabilitation: research and education priorities","volume":"20","author":"S McEwen","year":"2013","journal-title":"Curr Oncol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3747\/co.20.1316","article-title":"Endocrine therapy for postmenopausal women with hormone receptor-positive her2-negative advanced breast cancer after progression or recurrence on nonsteroidal aromatase inhibitor therapy: a Canadian consensus statement","volume":"20","author":"KI Pritchard","year":"2013","journal-title":"Curr Oncol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"e455","DOI":"10.3747\/co.20.1638","article-title":"Eastern Canadian Colorectal Cancer Consensus Conference: standards of care for the treatment of patients with rectal, pancreatic, and gastrointestinal stromal tumours and pancreatic neuroendocrine tumours","volume":"20","author":"T Di Valentin","year":"2013","journal-title":"Curr Oncol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3747\/co.v13i5.106","article-title":"Bortezomib in multiple myeloma and lymphoma: a systematic review and clinical practice guideline","volume":"13","author":"D Reece","year":"2006","journal-title":"Curr Oncol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3390\/curroncol13020006","article-title":"Guidelines for the diagnosis and management of carcinoid tumours. Part 1: the gastrointestinal tract. A statement from a Canadian National Carcinoid Expert Group","volume":"13","author":"J Maroun","year":"2006","journal-title":"Curr Oncol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3747\/co.v13i5.99","article-title":"Role of oxaliplatin combined with 5-fluorouracil and folinic acid in the first- and second-line treatment of advanced colorectal cancer","volume":"13","author":"D Jonker","year":"2006","journal-title":"Curr Oncol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3747\/co.2007.119","article-title":"Canadian recommendations for the treatment of glioblastoma multiforme","volume":"14","author":"WP Mason","year":"2007","journal-title":"Curr Oncol"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Quirt I, Verma S, Petrella T, Bak K, Charette M, et al. (2007) Temozolomide for the Treatment of Metastatic Melanoma: A Practice Guideline. Current Oncology, {S1}14.","DOI":"10.3747\/co.2007.98"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3747\/co.2007.130","article-title":"Ifosfamide-based combination chemotherapy in advanced soft-tissue sarcoma: a practice guideline","volume":"14","author":"S Verma","year":"2007","journal-title":"Curr Oncol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3747\/co.2007.129","article-title":"Management of single brain metastasis: a practice guideline","volume":"14","author":"A Mintz","year":"2007","journal-title":"Curr Oncol"},{"key":"ref33","unstructured":"Fraser G SC, Imrie K, Meyer R (2007) Alemtuzumab in Chronic Lymphocytic Leukemia: A Systematic Review and Clinical Practice Guideline. Current Oncology, {S1}14."},{"key":"ref34","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3747\/co.2007.97","article-title":"Single-Agent Interleukin-2 in the Treatment of Metastatic Melanoma: A Clinical Practice Guideline","volume":"14","author":"T Petrella","year":"2007","journal-title":"Curr Oncol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3747\/co.v15i2.173","article-title":"Biochemotherapy for the treatment of metastatic malignant melanoma: a clinical practice guideline","volume":"15","author":"S Verma","year":"2008","journal-title":"Curr Oncol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3747\/co.v15i2.162","article-title":"Dose-intensive chemotherapy with growth factor or autologous bone marrow or stem-cell transplant support in first-line treatment of advanced or metastatic adult soft tissue sarcoma: a clinical practice guideline","volume":"15","author":"S Verma","year":"2008","journal-title":"Curr Oncol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3747\/co.v17i3.520","article-title":"Epidermal growth factor receptor targeted therapy in stages III and IV head and neck cancer","volume":"17","author":"C Cripps","year":"2010","journal-title":"Curr Oncol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3747\/co.v17i3.514","article-title":"Follow-up for women after treatment for cervical cancer","volume":"17","author":"L Elit","year":"2010","journal-title":"Curr Oncol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"e250","DOI":"10.3747\/co.v18i5.775","article-title":"Canadian College of Medical Geneticists guidelines for the indications, analysis, and reporting of cancer specimens","volume":"18","author":"AJ Dawson","year":"2011","journal-title":"Curr Oncol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"e202","DOI":"10.3747\/co.v18i4.737","article-title":"Systemic therapy for advanced gastric cancer: a clinical practice guideline","volume":"18","author":"M Mackenzie","year":"2011","journal-title":"Curr Oncol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"e265","DOI":"10.3747\/co.v18i6.956","article-title":"Survivorship services for adult cancer populations: a pan-Canadian guideline","volume":"18","author":"D Howell","year":"2011","journal-title":"Curr Oncol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"e304","DOI":"10.3747\/co.v18i6.820","article-title":"Invasive mediastinal staging of non-small-cell lung cancer: a clinical practice guideline","volume":"18","author":"GE Darling","year":"2011","journal-title":"Curr Oncol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"e244","DOI":"10.3747\/co.19.980","article-title":"Management of a suspicious adnexal mass: a clinical practice guideline","volume":"19","author":"JE Dodge","year":"2012","journal-title":"Curr Oncol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"e136","DOI":"10.3747\/co.20.1252","article-title":"Lenalidomide in multiple myeloma-a practice guideline","volume":"20","author":"C Chen","year":"2013","journal-title":"Curr Oncol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"e448","DOI":"10.3747\/co.20.1357","article-title":"Chemotherapy (gemcitabine, docetaxel plus gemcitabine, doxorubicin, or trabectedin) in inoperable, locally advanced, recurrent, or metastatic uterine leiomyosarcoma: a clinical practice guideline","volume":"20","author":"AA Gupta","year":"2013","journal-title":"Curr Oncol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"e132","DOI":"10.3747\/co.20.1237","article-title":"Role of endolaryngeal surgery (with or without laser) compared with radiotherapy in the management of early (T1) glottic cancer: a clinical practice guideline","volume":"20","author":"J Yoo","year":"2013","journal-title":"Curr Oncol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"e247","DOI":"10.3747\/co.20.1308","article-title":"Surgical margins and handling of soft-tissue sarcoma in extremities: a clinical practice guideline","volume":"20","author":"R Kandel","year":"2013","journal-title":"Curr Oncol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"e255","DOI":"10.3747\/co.20.1341","article-title":"Liver resection for colorectal cancer metastases","volume":"20","author":"S Gallinger","year":"2013","journal-title":"Curr Oncol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"e233","DOI":"10.3747\/co.20.1302","article-title":"A pan-Canadian practice guideline and algorithm: screening, assessment, and supportive care of adults with cancer-related fatigue","volume":"20","author":"D Howell","year":"2013","journal-title":"Curr Oncol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.ejca.2006.01.025","article-title":"EORTC consensus recommendations for the treatment of mycosis fungoides\/S\u00e9zary syndrome","volume":"42","author":"F Trautinger","year":"2006","journal-title":"European journal of cancer (Oxford, England: 1990)"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/j.ejca.2006.04.012","article-title":"Towards a pan-European consensus on the treatment of patients with colorectal liver metastases","volume":"42","author":"E Van Cutsem","year":"2006","journal-title":"European journal of cancer (Oxford, England: 1990)"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.ejca.2007.12.008","article-title":"Consensus conference: Implementing treatment recommendations on yttrium-90 immunotherapy in clinical practice \u2013 Report of a European workshop","volume":"44","author":"PL Zinzani","year":"2008","journal-title":"European journal of cancer (Oxford, England: 1990)"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ejca.2009.10.032","article-title":"Diagnosis and treatment of melanoma: European consensus-based interdisciplinary guideline","volume":"46","author":"C Garbe","year":"2010","journal-title":"European journal of cancer (Oxford, England: 1990)"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1016\/j.ejca.2010.09.010","article-title":"Breast cancer in pregnancy: Recommendations of an international consensus meeting","volume":"46","author":"F Amant","year":"2010","journal-title":"European journal of cancer (Oxford, England: 1990)"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"S248","DOI":"10.1016\/S0959-8049(11)70171-X","article-title":"2010 Consensus on Lung Cancer, new clinical recommendations and current status of biomarker assessment \u2013 First-line therapy","volume":"47","author":"C Gridelli","year":"2011","journal-title":"European journal of cancer (Oxford, England : 1990)"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1016\/j.ejca.2012.07.029","article-title":"Highlights of the EORTC St. Gallen International Expert Consensus on the primary therapy of gastric, gastroesophageal and oesophageal cancer \u2013 Differential treatment strategies for subtypes of early gastroesophageal cancer","volume":"48","author":"MP Lutz","year":"2012","journal-title":"European journal of cancer (Oxford, England: 1990)"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1016\/j.ejca.2012.06.013","article-title":"Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline \u2013 Update 2012","volume":"48","author":"C Garbe","year":"2012","journal-title":"European journal of cancer (Oxford, England: 1990)"},{"key":"ref58","first-page":"2277","article-title":"European journal of cancer (Oxford, England: 1990)","volume":"49","author":"Austrian German","year":"2103"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.ejca.2005.02.004","article-title":"Guidelines for surgical treatment of hepatoblastoma in the modern era\u2013recommendations from the Childhood Liver Tumour Strategy Group of the International Society of Paediatric Oncology (SIOPEL)","volume":"41","author":"P Czauderna","year":"2005","journal-title":"Eur J Cancer"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.ejca.2005.11.018","article-title":"Malignant ascites: systematic review and guideline for treatment","volume":"42","author":"G Becker","year":"2006","journal-title":"Eur J Cancer"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1016\/j.ejca.2006.05.002","article-title":"EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours","volume":"42","author":"MS Aapro","year":"2006","journal-title":"Eur J Cancer"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ejca.2006.10.014","article-title":"EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update","volume":"43","author":"C Bokemeyer","year":"2007","journal-title":"Eur J Cancer"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/j.ejca.2007.03.021","article-title":"Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use","volume":"43","author":"MJ Duffy","year":"2007","journal-title":"Eur J Cancer"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.ejca.2006.12.008","article-title":"Guidelines on the standards for the training of specialised health professionals dealing with breast cancer","volume":"43","author":"L Cataliotti","year":"2007","journal-title":"Eur J Cancer"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ejca.2007.09.014","article-title":"Guidelines for the assessment of oral mucositis in adult chemotherapy, radiotherapy and haematopoietic stem cell transplant patients","volume":"44","author":"B Quinn","year":"2008","journal-title":"Eur J Cancer"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1016\/j.ejca.2009.05.001","article-title":"Diagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic patients: Guidelines of the infectious diseases working party of the German Society of Haematology and Oncology","volume":"45","author":"G Maschmeyer","year":"2009","journal-title":"Eur J Cancer"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.ejca.2010.01.023","article-title":"Glenny AM, Gibson F, Auld E, Coulson S, Clarkson JE, et al. The development of evidence-based guidelines on mouth care for children, teenagers and young adults treated for cancer","volume":"46","journal-title":"European Journal of Cancer"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ejca.2010.10.013","article-title":"2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours","volume":"47","author":"MS Aapro","year":"2011","journal-title":"Eur J Cancer"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.ejca.2010.11.027","article-title":"The development of evidence-based European guidelines on the management of depression in palliative cancer care","volume":"47","author":"L Rayner","year":"2011","journal-title":"Eur J Cancer"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.ejca.2011.01.013","article-title":"Paediatric intestinal cancer and polyposis due to bi-allelic PMS2 mutations: case series, review and follow-up guidelines","volume":"47","author":"JC Herkert","year":"2011","journal-title":"Eur J Cancer"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.ejca.2011.12.021","article-title":"EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma","volume":"48","journal-title":"Eur J Cancer"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1200\/JCO.2006.08.2305","article-title":"Use of Positron Emission Tomography for Response Assessment of Lymphoma: Consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma","volume":"25","author":"ME Juweid","year":"2007","journal-title":"Journal of Clinical Oncology"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1200\/JCO.2006.08.2313","article-title":"Definition, Diagnosis, and Management of Intravascular Large B-Cell Lymphoma: Proposals and Perspectives From an International Consensus Meeting","volume":"25","author":"M Ponzoni","year":"2007","journal-title":"Journal of Clinical Oncology"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"5660","DOI":"10.1200\/JCO.2009.21.9022","article-title":"Consensus Report of the National Cancer Institute Clinical Trials Planning Meeting on Pancreas Cancer Treatment","volume":"27","author":"PA Philip","year":"2009","journal-title":"Journal of Clinical Oncology"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1200\/JCO.2008.18.2428","article-title":"Definition, Prognostic Factors, Treatment, and Response Criteria of Adult T-Cell Leukemia-Lymphoma: A Proposal From an International Consensus Meeting","volume":"27","author":"K Tsukasaki","year":"2009","journal-title":"Journal of Clinical Oncology"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"4521","DOI":"10.1200\/JCO.2010.29.7929","article-title":"International Myeloma Working Group Consensus Statement Regarding the Current Status of Allogeneic Stem-Cell Transplantation for Multiple Myeloma","volume":"28","author":"H Lokhorst","year":"2010","journal-title":"Journal of Clinical Oncology"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"4976","DOI":"10.1200\/JCO.2010.30.8791","article-title":"Renal Impairment in Patients With Multiple Myeloma: A Consensus Statement on Behalf of the International Myeloma Working Group","volume":"28","author":"MA Dimopoulos","year":"2010","journal-title":"Journal of Clinical Oncology"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"3994","DOI":"10.1200\/JCO.2010.28.7805","article-title":"Hepatocellular Carcinoma: Consensus Recommendations of the National Cancer Institute Clinical Trials Planning Meeting","volume":"28","author":"MB Thomas","year":"2010","journal-title":"Journal of Clinical Oncology"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1200\/JCO.2010.33.2056","article-title":"Future Directions in the Treatment of Neuroendocrine Tumors: Consensus Report of the National Cancer Institute Neuroendocrine Tumor Clinical Trials Planning Meeting","volume":"29","author":"MH Kulke","year":"2011","journal-title":"Journal of Clinical Oncology"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1200\/JCO.2010.32.0630","article-title":"Clinical End Points and Response Criteria in Mycosis Fungoides and S\u00e9zary Syndrome: A Consensus Statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer","volume":"29","author":"EA Olsen","year":"2011","journal-title":"Journal of Clinical Oncology"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1200\/JCO.2011.39.1110","article-title":"Platinum-Induced Ototoxicity in Children: A Consensus Review on Mechanisms, Predisposition, and Protection, Including a New International Society of Pediatric Oncology Boston Ototoxicity Scale","volume":"30","author":"PR Brock","year":"2012","journal-title":"Journal of Clinical Oncology"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"7703","DOI":"10.1200\/JCO.2005.08.001","article-title":"American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer","volume":"23","author":"GH Lyman","year":"2005","journal-title":"J Clin Oncol"},{"key":"ref83","doi-asserted-by":"crossref","first-page":"8512","DOI":"10.1200\/JCO.2005.04.0063","article-title":"Colorectal Cancer Surveillance: 2005 Update of an American Society of Clinical Oncology Practice Guideline","volume":"23","author":"CE Desch","year":"2005","journal-title":"Journal of Clinical Oncology"},{"key":"ref84","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1200\/JCO.2006.09.2775","article-title":"American Society of Clinical Oncology\/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer","volume":"25","author":"AC Wolff","year":"2006","journal-title":"Journal of Clinical Oncology"},{"key":"ref85","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1200\/JCO.2006.06.4451","article-title":"2006 Update of Recommendations for the Use of White Blood Cell Growth Factors: An Evidence-Based Clinical Practice Guideline","volume":"24","author":"TJ Smith","year":"2006","journal-title":"Journal of Clinical Oncology"},{"key":"ref86","doi-asserted-by":"crossref","first-page":"3693","DOI":"10.1200\/JCO.2006.07.4559","article-title":"American Society of Clinical Oncology Clinical Practice Guideline for the Use of Larynx-Preservation Strategies in the Treatment of Laryngeal Cancer","volume":"24","author":"DG Pfister","year":"2006","journal-title":"Journal of Clinical Oncology"},{"key":"ref87","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.1200\/JCO.2006.06.9591","article-title":"American Society of Clinical Oncology Guideline for Antiemetics in Oncology: Update 2006","volume":"24","author":"MG Kris","year":"2006","journal-title":"Journal of Clinical Oncology"},{"key":"ref88","doi-asserted-by":"crossref","first-page":"5490","DOI":"10.1200\/JCO.2007.14.1283","article-title":"American Society of Clinical Oncology Guideline: Recommendations for Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer","volume":"25","author":"GH Lyman","year":"2007","journal-title":"Journal of Clinical Oncology"},{"key":"ref89","doi-asserted-by":"crossref","first-page":"5506","DOI":"10.1200\/JCO.2007.14.1226","article-title":"Cancer Care Ontario and American Society of Clinical Oncology Adjuvant Chemotherapy and Adjuvant Radiation Therapy for Stages I-IIIA Resectable Non\u2013Small-Cell Lung Cancer Guideline","volume":"25","author":"KMW Pisters","year":"2007","journal-title":"Journal of Clinical Oncology"},{"key":"ref90","doi-asserted-by":"crossref","first-page":"5313","DOI":"10.1200\/JCO.2007.13.4536","article-title":"American Society of Clinical Oncology Endorsement of the Cancer Care Ontario Practice Guideline on Nonhormonal Therapy for Men With Metastatic Hormone-Refractory (castration-resistant) Prostate Cancer","volume":"25","author":"EM Basch","year":"2007","journal-title":"Journal of Clinical Oncology"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1200\/JCO.2007.12.1269","article-title":"American Society of Clinical Oncology 2007 Clinical Practice Guideline Update on the Role of Bisphosphonates in Multiple Myeloma","volume":"25","author":"RA Kyle","year":"2007","journal-title":"Journal of Clinical Oncology"},{"key":"ref92","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1200\/JCO.2006.10.1949","article-title":"Initial Hormonal Management of Androgen-Sensitive Metastatic, Recurrent, or Progressive Prostate Cancer: 2007 Update of an American Society of Clinical Oncology Practice Guideline","volume":"25","author":"DA Loblaw","year":"2007","journal-title":"Journal of Clinical Oncology"},{"key":"ref93","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1200\/JCO.2008.17.2627","article-title":"American Society of Clinical Oncology 2008 Clinical Practice Guideline Update: Use of Chemotherapy and Radiation Therapy Protectants","volume":"27","author":"ML Hensley","year":"2009","journal-title":"Journal of Clinical Oncology"},{"key":"ref94","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1200\/JCO.2008.16.9599","article-title":"Use of 5-alpha-reductase inhibitors for prostate cancer chemoprevention: American Society of Clinical Oncology\/American Urological Association 2008 Clinical Practice Guideline","volume":"27","author":"BS Kramer","year":"2009","journal-title":"J Clin Oncol"},{"key":"ref95","doi-asserted-by":"crossref","first-page":"6251","DOI":"10.1200\/JCO.2009.23.5622","article-title":"American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non\u2013Small-Cell Lung Cancer","volume":"27","author":"CG Azzoli","year":"2009","journal-title":"Journal of Clinical Oncology"},{"key":"ref96","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1200\/JCO.2008.20.5179","article-title":"American Society of Clinical Oncology Clinical Practice Guideline Update on the Use of Pharmacologic Interventions Including Tamoxifen, Raloxifene, and Aromatase Inhibition for Breast Cancer Risk Reduction","volume":"27","author":"K Visvanathan","year":"2009","journal-title":"Journal of Clinical Oncology"},{"key":"ref97","doi-asserted-by":"crossref","first-page":"4996","DOI":"10.1200\/JCO.2010.29.2201","article-title":"American Society of Clinical Oncology\/American Society of Hematology Clinical Practice Guideline Update on the Use of Epoetin and Darbepoetin in Adult Patients With Cancer","volume":"28","author":"JD Rizzo","year":"2010","journal-title":"Journal of Clinical Oncology"},{"key":"ref98","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1200\/JCO.2009.26.3756","article-title":"American Society of Clinical Oncology Clinical Practice Guideline: Update on Adjuvant Endocrine Therapy for Women With Hormone Receptor\u2013Positive Breast Cancer","volume":"28","author":"HJ Burstein","year":"2010","journal-title":"Journal of Clinical Oncology"},{"key":"ref99","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1200\/JCO.2009.26.4481","article-title":"American Society of Clinical Oncology Clinical Practice Guideline on Uses of Serum Tumor Markers in Adult Males With Germ Cell Tumors","volume":"28","author":"TD Gilligan","year":"2010","journal-title":"Journal of Clinical Oncology"},{"key":"ref100","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1200\/JCO.2009.25.6529","article-title":"American Society of Clinical Oncology\/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer","volume":"28","author":"MEH Hammond","year":"2010","journal-title":"Journal of Clinical Oncology"},{"key":"ref101","doi-asserted-by":"crossref","first-page":"4189","DOI":"10.1200\/JCO.2010.34.4614","article-title":"Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update","volume":"29","author":"E Basch","year":"2011","journal-title":"Journal of Clinical Oncology"},{"key":"ref102","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.1200\/JCO.2011.36.4950","article-title":"American Society of Clinical Oncology Endorsement of the Cancer Care Ontario Practice Guideline on Adjuvant Ovarian Ablation in the Treatment of Premenopausal Women With Early-Stage Invasive Breast Cancer","volume":"29","author":"JJ Griggs","year":"2011","journal-title":"Journal of Clinical Oncology"},{"key":"ref103","doi-asserted-by":"crossref","first-page":"3825","DOI":"10.1200\/JCO.2010.34.2774","article-title":"2011 Focused Update of 2009 American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non\u2013Small-Cell Lung Cancer","volume":"29","author":"CG Azzoli","year":"2011","journal-title":"Journal of Clinical Oncology"},{"key":"ref104","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.1200\/JCO.2011.36.0354","article-title":"American Society of Clinical Oncology Clinical Practice Guideline Update on the Use of Chemotherapy Sensitivity and Resistance Assays","volume":"29","author":"HJ Burstein","year":"2011","journal-title":"Journal of Clinical Oncology"},{"key":"ref105","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1200\/JCO.2011.40.3519","article-title":"Sentinel Lymph Node Biopsy for Melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Joint Clinical Practice Guideline","volume":"30","author":"SL Wong","year":"2012","journal-title":"Journal of Clinical Oncology"},{"key":"ref106","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1200\/JCO.2011.39.9436","article-title":"Appropriate Chemotherapy Dosing for Obese Adult Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline","volume":"30","author":"JJ Griggs","year":"2012","journal-title":"Journal of Clinical Oncology"},{"key":"ref107","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1200\/JCO.2013.49.3122","article-title":"Use of Pharmacologic Interventions for Breast Cancer Risk Reduction: American Society of Clinical Oncology Clinical Practice Guideline","volume":"31","author":"K Visvanathan","year":"2013","journal-title":"Journal of Clinical Oncology"},{"key":"ref108","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1200\/JCO.2013.49.2678","article-title":"Fertility Preservation for Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update","volume":"31","author":"AW Loren","year":"2013","journal-title":"Journal of Clinical Oncology"},{"key":"ref109","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1200\/JCO.2012.45.5733","article-title":"Central venous catheter care for the patient with cancer: American Society of Clinical Oncology clinical practice guideline","volume":"31","author":"CA Schiffer","year":"2013","journal-title":"J Clin Oncol"},{"key":"ref110","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1200\/JCO.2012.45.9859","article-title":"Breast Cancer Follow-Up and Management After Primary Treatment: American Society of Clinical Oncology Clinical Practice Guideline Update","volume":"31","author":"JL Khatcheressian","year":"2013","journal-title":"Journal of Clinical Oncology"},{"key":"ref111","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1200\/JCO.2012.45.8661","article-title":"Antimicrobial Prophylaxis and Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology Clinical Practice Guideline","volume":"31","author":"CR Flowers","year":"2013","journal-title":"Journal of Clinical Oncology"},{"key":"ref112","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/intqhc\/mzi011","article-title":"Predictors of high quality clinical practice guidelines: examples in oncology","volume":"17","author":"B Fervers","year":"2005","journal-title":"Int J Qual Health Care"},{"key":"ref113","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1200\/JCO.2004.06.157","article-title":"International assessment of the quality of clinical practice guidelines in oncology using the Appraisal of Guidelines and Research and Evaluation Instrument","volume":"22","author":"JS Burgers","year":"2004","journal-title":"J Clin Oncol"},{"key":"ref114","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1111\/j.1468-3083.2007.02216.x","article-title":"Quality of clinical practice guidelines in dermatological oncology","volume":"21","author":"ER de Haas","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref115","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s10147-010-0060-y","article-title":"Quality of guideline development assessed by the Evaluation Committee of the Japan Society of Clinical Oncology","volume":"15","author":"T Shimbo","year":"2010","journal-title":"Int J Clin Oncol"},{"key":"ref116","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1038\/bjc.2011.378","article-title":"The quality of web-based oncology guidelines and protocols: how do international sites stack up?","volume":"105","author":"JM Langton","year":"2011","journal-title":"Br J Cancer"},{"key":"ref117","doi-asserted-by":"crossref","first-page":"e184","DOI":"10.3747\/co.19.930","article-title":"Comparison of international breast cancer guidelines: are we globally consistent? cancer guideline AGREEment","volume":"19","author":"SE Hogeveen","year":"2012","journal-title":"Curr Oncol"},{"key":"ref118","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1002\/art.24207","article-title":"Quality appraisal of clinical practice guidelines and consensus statements on the use of biologic agents in rheumatoid arthritis: a systematic review","volume":"59","author":"MA Lopez-Olivo","year":"2008","journal-title":"Arthritis Rheum"},{"key":"ref119","unstructured":"Collaboration TC (2014) Understanding Searching Techniques to Inform HTA, Systematic Reviews and Guideline Development."},{"key":"ref120","doi-asserted-by":"crossref","unstructured":"Graham R, Mancher M, Wolman DM, Greenfield S, Steinberg E (2011) Clinical Practice Guidelines We Can Trust. The National Academies Press.","DOI":"10.17226\/13058"},{"key":"ref121","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1001\/archinternmed.2011.96","article-title":"COnflicts of interest in cardiovascular clinical practice guidelines","volume":"171","author":"TB Mendelson","year":"2011","journal-title":"Archives of Internal Medicine"},{"key":"ref122","unstructured":"American Society of Clinical Oncology (2013) Conflict of Interest Policy Implementation for Clinical Practice Guidelines of American Society of Clinical Oncology. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.asco.org\/sites\/www.asco.org\/files\/conflict_of_interest_policy_implementation_for_clinical_practice_guidelines_8.8.2013_0.pdf\" xlink:type=\"simple\">http:\/\/www.asco.org\/sites\/www.asco.org\/files\/conflict_of_interest_policy_implementation_for_clinical_practice_guidelines_8.8.2013_0.pdf<\/ext-link> [Accessed 28 May 2014]."},{"key":"ref123","doi-asserted-by":"crossref","first-page":"e25153","DOI":"10.1371\/journal.pone.0025153","article-title":"Conflict of interest in clinical practice guideline development: a systematic review","volume":"6","author":"SL Norris","year":"2011","journal-title":"PLoS One"},{"key":"ref124","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/jep.12016","article-title":"Conflicts of interest and the quality of recommendations in clinical guidelines","volume":"19","author":"L Cosgrove","year":"2013","journal-title":"Journal of Evaluation in Clinical Practice"}],"updated-by":[{"DOI":"10.1371\/journal.pone.0116267","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2014,12,17]],"date-time":"2014-12-17T00:00:00Z","timestamp":1418774400000}}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0110469","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T03:31:47Z","timestamp":1746415907000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0110469"}},"subtitle":[],"editor":[{"given":"Eugenio","family":"Paci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,10,17]]},"references-count":124,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2014,10,17]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0110469","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.723347444.793504770","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,17]]}}}